April 1, 2003Arteriosclerosis Thrombosis and Vascular Biology
Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase Pathway
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Suggests NO pathway as target for cardiac allograft vasculopathy therapy; leaves open whether modulation alters clinical outcomes.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Weis et al. (2003) studied this question.